CPT-11 (irinotecan)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CPT-11 (irinotecan), covering 2009-09-28 to 2023-02-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM [Phase 2]